Light chain cardiac amyloidosis
Clinical trials for Light chain cardiac amyloidosis explained in plain language.
Never miss a new study
Get alerted when new Light chain cardiac amyloidosis trials appear
Sign up with your email to follow new studies for Light chain cardiac amyloidosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Triple-Drug combo tame a rare heart disease?
Disease control Not yet recruitingThis phase II trial is testing whether a combination of selinexor, daratumumab, and dexamethasone (called XDd) can help people with advanced light-chain cardiac amyloidosis, a condition where abnormal proteins build up in the heart. The study aims to see if the regimen can achiev…
Matched conditions: LIGHT CHAIN CARDIAC AMYLOIDOSIS
Phase 2 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New cell therapy trial targets Hard-to-Treat heart amyloidosis
Disease control Not yet recruitingThis study tests a new treatment for people with a rare disease called light-chain cardiac amyloidosis that has come back or not responded to other treatments. The treatment uses specially engineered immune cells (CAR-NK cells) from donated umbilical cord blood to target and atta…
Matched conditions: LIGHT CHAIN CARDIAC AMYLOIDOSIS
Phase 1/2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC